SC 13G/A

ARCH VENTURE FUND VIII, L.P. - DENALI THERAPEUTICS INC. -- SCH 13G/A (#2)

Company: Denali Therapeutics Inc.
Filed: February 2, 2021
Accession Number: 0001072613-21-000074

View Document ↗ View on SEC.gov ↗